ChinaBio Today -- September 18, 2009 -- At the recent ChinaBio® Day, held on Tuesday, September 15 in San Francisco in conjunction with BioPharma America™, four panel presentations centered their discussions on specific features of the China biopharma sector. In the “Financial Crisis” panel, representatives of the financial sector shared their insights on the 2009 version of China’s life science. The discussion ranged over several topics, including government incentives, innovation, corporate structure and over-incentivizing. More details..
